Publications by authors named "Alexey Simakov"

Claim this Profile
N
Nrf2 Activation and Antioxidant Properties of Chromone-Containing MTDLs for Alzheimer's Disease Treatment.
Alexey Simakov, Stecy Chhor, Lhassane Ismaili, Hélène Martin

Molecules· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of New Highly Potent Histamine H Receptor Antagonists, Calcium Channel Blockers, and Acetylcholinesterase Inhibitors.
Rim Malek, Kinga Sałat, Perle Totoson, Tadeusz Karcz, Bernard Refouvelet, Alexey Simakov

ACS Chem Neurosci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties.
Irene Pachón-Angona, Paul J Bernard, Alexey Simakov, Maciej Maj, Krzysztof Jozwiak

Pharmaceutics· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer's Disease Treatment.
Imen Dakhlaoui, Paul J Bernard, Diana Pietrzak, Alexey Simakov, Maciej Maj

Int J Mol Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation.
Rim Malek, Alexey Simakov, Audrey Davis, Maciej Maj, Paul J Bernard

Molecules· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis